These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 32088090)

  • 1. Mutational and expressional alterations of a candidate tumor suppressor HECA gene in gastric and colorectal cancers.
    Son HJ; Choi EJ; Yoo NJ; Lee SH
    Pathol Res Pract; 2020 May; 216(5):152896. PubMed ID: 32088090
    [No Abstract]   [Full Text] [Related]  

  • 2. Frameshift mutation of candidate tumor suppressor genes QK1 and TMEFF2 in gastric and colorectal cancers.
    Mo HY; Jo YS; Yoo NJ; Kim MS; Song SY; Lee SH
    Cancer Biomark; 2019; 24(1):1-6. PubMed ID: 30614793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frameshift mutations of tumor suppressor gene EP300 in gastric and colorectal cancers with high microsatellite instability.
    Kim MS; Lee SH; Yoo NJ; Lee SH
    Hum Pathol; 2013 Oct; 44(10):2064-70. PubMed ID: 23759652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candidate Tumor Suppressor Gene EAF2 is Mutated in Colorectal and Gastric Cancers.
    Jo YS; Kim SS; Kim MS; Yoo NJ; Lee SH
    Pathol Oncol Res; 2019 Apr; 25(2):823-824. PubMed ID: 30088132
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic and expressional alterations of CHD genes in gastric and colorectal cancers.
    Kim MS; Chung NG; Kang MR; Yoo NJ; Lee SH
    Histopathology; 2011 Apr; 58(5):660-8. PubMed ID: 21447119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational and expressional analysis of a haploinsufficient tumor suppressor gene DOK2 in gastric and colorectal cancers.
    An CH; Kim MS; Yoo NJ; Lee SH
    APMIS; 2011 Aug; 119(8):562-4. PubMed ID: 21749457
    [No Abstract]   [Full Text] [Related]  

  • 7. Inactivating frameshift mutation of putative tumor suppressor genes PLA2R1 and SRPK1 in gastric and colorectal cancers.
    Lee JH; Jo YS; Kim MS; Yoo NJ; Lee SH
    Cancer Genet; 2017 Jan; 210():34-35. PubMed ID: 28212809
    [No Abstract]   [Full Text] [Related]  

  • 8. Inactivating Frameshift Mutations of HACD4 and TCP10L Tumor Suppressor Genes in Colorectal and Gastric Cancers.
    Jo YS; Kim MS; Yoo NJ; Lee SH
    Pathol Oncol Res; 2020 Jan; 26(1):583-584. PubMed ID: 29532408
    [No Abstract]   [Full Text] [Related]  

  • 9. Frameshift Mutations of CAB39L, an Activator of LKB1 Tumor Suppressor, in Gastric and Colorectal Cancers.
    Choi MR; An CH; Yoo NJ; Lee SH
    Pathol Oncol Res; 2016 Jan; 22(1):225-6. PubMed ID: 26306467
    [No Abstract]   [Full Text] [Related]  

  • 10. Mutational and expressional analysis of SMC2 gene in gastric and colorectal cancers with microsatellite instability.
    Je EM; Yoo NJ; Lee SH
    APMIS; 2014 Jun; 122(6):499-504. PubMed ID: 24483990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation and Expression of a Candidate Tumor Suppressor Gene EPB41L3 in Gastric and Colorectal Cancers.
    Son HJ; Choi EJ; Yoo NJ; Lee SH
    Pathol Oncol Res; 2020 Jul; 26(3):2003-2005. PubMed ID: 31828581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frameshift mutations of MUC15 gene in gastric and its regional heterogeneity in gastric and colorectal cancers.
    Oh HR; An CH; Yoo NJ; Lee SH
    Pathol Oncol Res; 2015 Jul; 21(3):713-8. PubMed ID: 25573589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational and expressional alterations of ZMPSTE24, DNA damage response-related gene, in gastric and colorectal cancers.
    Lee JH; Yoo NJ; Kim MS; An CH; Lee SH
    Pathol Res Pract; 2016 Dec; 212(12):1113-1118. PubMed ID: 27729169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic mutation and loss of expression of a candidate tumor suppressor gene TET3 in gastric and colorectal cancers.
    Mo HY; An CH; Choi EJ; Yoo NJ; Lee SH
    Pathol Res Pract; 2020 Mar; 216(3):152759. PubMed ID: 31859118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic characteristics related to the high variability of coding mononucleotide repeat sequences in tumors with high-microsatellite instability.
    Chung KY; Kim NG; Li LS; Kim H; Kim H; Nam CM; Kim H; Shin DH
    Oncol Rep; 2003; 10(2):439-44. PubMed ID: 12579286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expressional and mutational analysis of CREBBP gene in gastric and colorectal cancers with microsatellite instability.
    Kim MS; Yoo NJ; Lee SH
    Pathol Oncol Res; 2014 Jan; 20(1):221-2. PubMed ID: 23839013
    [No Abstract]   [Full Text] [Related]  

  • 17. Frameshift mutation of a tumor suppressor gene PALB2 in gastric and colorectal cancers with microsatellite instability.
    Kim MS; Lee SH; Yoo NJ; Lee SH
    APMIS; 2013 Oct; 121(10):1015-6. PubMed ID: 23758548
    [No Abstract]   [Full Text] [Related]  

  • 18. Frequent frameshift mutations in 2 mononucleotide repeats of RNF43 gene and its regional heterogeneity in gastric and colorectal cancers.
    Jo YS; Kim MS; Lee JH; Lee SH; An CH; Yoo NJ
    Hum Pathol; 2015 Nov; 46(11):1640-6. PubMed ID: 26297255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivating frameshift mutation of PBRM1, a putative tumour suppressor gene, in colorectal cancers.
    Jo YS; Kim MS; Yoo NJ; Lee SH
    Scand J Gastroenterol; 2016; 51(5):639-40. PubMed ID: 26634388
    [No Abstract]   [Full Text] [Related]  

  • 20. Frameshift Mutation of FXR1 Encoding a RNA-Binding Protein in Gastric and Colorectal Cancers with Microsatellite Instability.
    Jo YS; Kim SS; Kim MS; Yoo NJ; Lee SH
    Pathol Oncol Res; 2017 Apr; 23(2):453-454. PubMed ID: 28028731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.